 | A1AYB | Name: | N-methyl-1-{4-[(pyridin-2-yl)oxy]phenyl}methanamine | Formula: | C13 H14 N2 O | SMILES: | CNCc1ccc(cc1)Oc1ccccn1 | InChi: | InChI=1S/C13H14N2O/c1-14-10-11-5-7-12(8-6-11)16-13-4-2-3-9-15-13/h2-9,14H,10H2,1H3 | Definition date: | 2024-07-11 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | N-methyl-1-{4-[(pyridin-2-yl)oxy]phenyl}methanamine |
|
 | A1AYF | Name: | (3aR,7aS)-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione | Formula: | C8 H9 N O2 | SMILES: | O=C1NC(=O)C2CC=CCC12 | InChi: | InChI=1S/C8H9NO2/c10-7-5-3-1-2-4-6(5)8(11)9-7/h1-2,5-6H,3-4H2,(H,9,10,11)/t5-,6+ | Definition date: | 2024-07-11 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | (3aR,7aS)-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione |
|
 | A1AYQ | Name: | (4R)-5-chloro-3-ethyl[1,2,4]triazolo[4,3-a]pyridine | Formula: | C8 H8 Cl N3 | SMILES: | Clc1cccc2nnc(CC)n12 | InChi: | InChI=1S/C8H8ClN3/c1-2-7-10-11-8-5-3-4-6(9)12(7)8/h3-5H,2H2,1H3 | Definition date: | 2024-07-11 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | (4R)-5-chloro-3-ethyl[1,2,4]triazolo[4,3-a]pyridine |
|
 | A1AYR | Name: | 3-(3-bromothiophen-2-yl)-1H-pyrazole | Formula: | C7 H5 Br N2 S | SMILES: | Brc1ccsc1c1n[NH]cc1 | InChi: | InChI=1S/C7H5BrN2S/c8-5-2-4-11-7(5)6-1-3-9-10-6/h1-4H,(H,9,10) | Definition date: | 2024-07-11 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | 3-(3-bromothiophen-2-yl)-1H-pyrazole |
|
 | A1AYU | Name: | 2-phenyl-5-(trifluoromethyl)-1,2-dihydro-3H-pyrazol-3-one | Formula: | C10 H7 F3 N2 O | SMILES: | FC(F)(F)C1=CC(=O)N(N1)c1ccccc1 | InChi: | InChI=1S/C10H7F3N2O/c11-10(12,13)8-6-9(16)15(14-8)7-4-2-1-3-5-7/h1-6,14H | Definition date: | 2024-07-11 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | 2-phenyl-5-(trifluoromethyl)-1,2-dihydro-3H-pyrazol-3-one |
|
 | A1AYY | Name: | [6-(pyrrolidin-1-yl)pyridin-2-yl]methanol | Formula: | C10 H14 N2 O | SMILES: | OCc1cccc(n1)N1CCCC1 | InChi: | InChI=1S/C10H14N2O/c13-8-9-4-3-5-10(11-9)12-6-1-2-7-12/h3-5,13H,1-2,6-8H2 | Definition date: | 2024-07-11 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | [6-(pyrrolidin-1-yl)pyridin-2-yl]methanol |
|
 | A1B0W | Name: | N-[3-(azepan-1-yl)propyl]-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]quinoline-2-carboxamide | Formula: | C22 H27 N3 O2 S | SMILES: | O=C(NCCCN1CCCCCC1)c1cc2C(=O)N(C)c3ccccc3c2s1 | InChi: | InChI=1S/C22H27N3O2S/c1-24-18-10-5-4-9-16(18)20-17(22(24)27)15-19(28-20)21(26)23-11-8-14-25-12-6-2-3-7-13-25/h4-5,9-10,15H,2-3,6-8,11-14H2,1H3,(H,23,26) | Definition date: | 2025-03-18 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | N-[3-(azepan-1-yl)propyl]-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]quinoline-2-carboxamide |
|
 | A1BUB | Name: | 2-hydroxy-4-methylbenzoic acid | Formula: | C8 H8 O3 | SMILES: | OC(=O)c1ccc(C)cc1O | InChi: | InChI=1S/C8H8O3/c1-5-2-3-6(8(10)11)7(9)4-5/h2-4,9H,1H3,(H,10,11) | Synonyms: | 4-methyl salicylic acid | Definition date: | 2025-01-22 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | 2-hydroxy-4-methylbenzoic acid |
|
 | A1BWS | Name: | (3S)-4-{[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino}-3-hydroxy-4-oxobutanoic acid | Formula: | C10 H18 N2 O5 | SMILES: | O=C(O)CC(O)C(=O)NC(CC(C)C)C(N)=O | InChi: | InChI=1S/C10H18N2O5/c1-5(2)3-6(9(11)16)12-10(17)7(13)4-8(14)15/h5-7,13H,3-4H2,1-2H3,(H2,11,16)(H,12,17)(H,14,15)/t6-,7-/m0/s1 | Definition date: | 2025-02-14 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | (3S)-4-{[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino}-3-hydroxy-4-oxobutanoic acid |
|
 | A1BWT | Name: | (3R)-4-({(2S)-1-[(5-acetamidopentyl)amino]-1-oxo-3-phenylpropan-2-yl}amino)-3-hydroxy-4-oxobutanoic acid | Formula: | C20 H29 N3 O6 | SMILES: | O=C(O)CC(O)C(=O)NC(Cc1ccccc1)C(=O)NCCCCCNC(C)=O | InChi: | InChI=1S/C20H29N3O6/c1-14(24)21-10-6-3-7-11-22-19(28)16(12-15-8-4-2-5-9-15)23-20(29)17(25)13-18(26)27/h2,4-5,8-9,16-17,25H,3,6-7,10-13H2,1H3,(H,21,24)(H,22,28)(H,23,29)(H,26,27)/t16-,17+/m0/s1 | Definition date: | 2025-02-14 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | (3R)-4-({(2S)-1-[(5-acetamidopentyl)amino]-1-oxo-3-phenylpropan-2-yl}amino)-3-hydroxy-4-oxobutanoic acid |
|
 | 9CP | Name: | (2S,5R)-1-formyl-4-methyl-5-[(sulfooxy)amino]-1,2,5,6-tetrahydropyridine-2-carboxamide | Formula: | C8 H13 N3 O6 S | SMILES: | O=CN1CC(NOS(=O)(=O)O)C(C)=CC1C(N)=O | InChi: | InChI=1S/C8H13N3O6S/c1-5-2-7(8(9)13)11(4-12)3-6(5)10-17-18(14,15)16/h2,4,6-7,10H,3H2,1H3,(H2,9,13)(H,14,15,16)/t6-,7-/m0/s1 | Definition date: | 2017-04-19 | Last modified: | 2025-03-19 | Release date: | 2017-06-07 | Identifier: | (2S,5R)-1-formyl-4-methyl-5-[(sulfooxy)amino]-1,2,5,6-tetrahydropyridine-2-carboxamide |
|
 | WK6 | Name: | L-gamma-glutamyl-S-(benzylcarbamothioyl)-L-cysteinylglycine | Formula: | C18 H24 N4 O6 S2 | SMILES: | O=C(O)C(N)CCC(=O)NC(CSC(=S)NCc1ccccc1)C(=O)NCC(=O)O | InChi: | InChI=1S/C18H24N4O6S2/c19-12(17(27)28)6-7-14(23)22-13(16(26)20-9-15(24)25)10-30-18(29)21-8-11-4-2-1-3-5-11/h1-5,12-13H,6-10,19H2,(H,20,26)(H,21,29)(H,22,23)(H,24,25)(H,27,28)/t12-,13+/m0/s1 | Definition date: | 2023-10-05 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | L-gamma-glutamyl-S-(benzylcarbamothioyl)-L-cysteinylglycine |
|
 | A1EBD | Name: | piperidine-4-sulfonic acid | Formula: | C5 H11 N O3 S | SMILES: | O[S](=O)(=O)C1CCNCC1 | InChi: | InChI=1S/C5H11NO3S/c7-10(8,9)5-1-3-6-4-2-5/h5-6H,1-4H2,(H,7,8,9) | Definition date: | 2024-09-02 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | piperidine-4-sulfonic acid |
|
 | UJT | Name: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl-(3-oxidanylpropyl)amino]methyl]oxolane-3,4-diol | Formula: | C26 H33 N11 O8 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CN(CCCO)CC#Cc4nc5c(N)ncnc5n4[CH]6O[CH](CO)[CH](O)[CH]6O)[CH](O)[CH]3O | InChi: | InChI=1S/C26H33N11O8/c27-21-15-23(31-9-29-21)36(11-33-15)25-19(42)17(40)12(44-25)7-35(5-2-6-38)4-1-3-14-34-16-22(28)30-10-32-24(16)37(14)26-20(43)18(41)13(8-39)45-26/h9-13,17-20,25-26,38-43H,2,4-8H2,(H2,27,29,31)(H2,28,30,32)/t12-,13+,17+,18+,19+,20+,25-,26-/m0/s1 | Definition date: | 2023-09-06 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl-(3-oxidanylpropyl)amino]methyl]oxolane-3,4-diol |
|
 | ULU | Name: | ~{N}-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]propyl]-3-[(azanylidene-$l^{4}-azanylidene)amino]propanamide | Formula: | C29 H38 N15 O8 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CN(CCCNC(=O)CCN=[N]=N)CC#Cc4nc5c(N)ncnc5n4[CH]6O[CH](CO)[CH](O)[CH]6O)[CH](O)[CH]3O | InChi: | InChI=1S/C29H38N15O8/c30-24-18-26(36-11-34-24)43(13-38-18)28-22(49)20(47)14(51-28)9-42(8-2-5-33-17(46)4-6-39-41-32)7-1-3-16-40-19-25(31)35-12-37-27(19)44(16)29-23(50)21(48)15(10-45)52-29/h11-15,20-23,28-29,32,45,47-50H,2,4-10H2,(H,33,46)(H2,30,34,36)(H2,31,35,37)/t14-,15+,20+,21+,22+,23+,28-,29-/m0/s1 | Definition date: | 2023-09-06 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | ~{N}-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]propyl]-3-[(azanylidene-$l^{4}-azanylidene)amino]propanamide |
|
 | UMU | Name: | 1-[[(2~{R},3~{S},4~{R},5~{R})-5-[8-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy]prop-1-ynyl]-6-azanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl]-3-ethyl-urea | Formula: | C26 H32 N12 O8 | SMILES: | CCNC(=O)NC[CH]1O[CH]([CH](O)[CH]1O)n2c(nc3c(N)ncnc23)C#CCOC[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56 | InChi: | InChI=1S/C26H32N12O8/c1-2-29-26(43)30-6-11-16(39)19(42)25(45-11)38-13(36-15-21(28)32-9-34-23(15)38)4-3-5-44-7-12-17(40)18(41)24(46-12)37-10-35-14-20(27)31-8-33-22(14)37/h8-12,16-19,24-25,39-42H,2,5-7H2,1H3,(H2,27,31,33)(H2,28,32,34)(H2,29,30,43)/t11-,12-,16-,17-,18-,19-,24-,25-/m1/s1 | Definition date: | 2023-09-06 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 1-[[(2~{R},3~{S},4~{R},5~{R})-5-[8-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy]prop-1-ynyl]-6-azanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl]-3-ethyl-urea |
|
 | WQN | Name: | 1-[8-(4-bromophenyl)sulfonyl-5-oxa-2,8-diazaspiro[3.5]nonan-2-yl]-2-chloranyl-ethanone | Formula: | C14 H16 Br Cl N2 O4 S | SMILES: | ClCC(=O)N1CC2(C1)CN(CCO2)[S](=O)(=O)c3ccc(Br)cc3 | InChi: | InChI=1S/C14H16BrClN2O4S/c15-11-1-3-12(4-2-11)23(20,21)18-5-6-22-14(10-18)8-17(9-14)13(19)7-16/h1-4H,5-10H2 | Definition date: | 2023-10-10 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 1-[8-(4-bromophenyl)sulfonyl-5-oxa-2,8-diazaspiro[3.5]nonan-2-yl]-2-chloranyl-ethanone |
|
 | WQT | Name: | 2-chloranyl-1-[8-(4-iodophenyl)sulfonyl-5-oxa-2,8-diazaspiro[3.5]nonan-2-yl]ethanone | Formula: | C14 H16 Cl I N2 O4 S | SMILES: | ClCC(=O)N1CC2(C1)CN(CCO2)[S](=O)(=O)c3ccc(I)cc3 | InChi: | InChI=1S/C14H16ClIN2O4S/c15-7-13(19)17-8-14(9-17)10-18(5-6-22-14)23(20,21)12-3-1-11(16)2-4-12/h1-4H,5-10H2 | Definition date: | 2023-10-10 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 2-chloranyl-1-[8-(4-iodophenyl)sulfonyl-5-oxa-2,8-diazaspiro[3.5]nonan-2-yl]ethanone |
|
 | UOL | Name: | 1-[[(2~{R},3~{S},4~{R},5~{R})-5-[8-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-methyl-amino]prop-1-ynyl]-6-azanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl]-3-ethyl-urea | Formula: | C27 H35 N13 O7 | SMILES: | CCNC(=O)NC[CH]1O[CH]([CH](O)[CH]1O)n2c(nc3c(N)ncnc23)C#CCN(C)C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56 | InChi: | InChI=1S/C27H35N13O7/c1-3-30-27(45)31-7-12-17(41)20(44)26(46-12)40-14(37-16-22(29)33-10-35-24(16)40)5-4-6-38(2)8-13-18(42)19(43)25(47-13)39-11-36-15-21(28)32-9-34-23(15)39/h9-13,17-20,25-26,41-44H,3,6-8H2,1-2H3,(H2,28,32,34)(H2,29,33,35)(H2,30,31,45)/t12-,13-,17-,18-,19-,20-,25-,26-/m1/s1 | Definition date: | 2023-09-06 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 1-[[(2~{R},3~{S},4~{R},5~{R})-5-[8-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-methyl-amino]prop-1-ynyl]-6-azanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl]-3-ethyl-urea |
|
 | A1H5Q | Name: | 6-[[2-[1-(6-methoxy-1,5-naphthyridin-4-yl)-1,2,3-triazol-4-yl]ethylamino]methyl]-4H-1,4-benzothiazin-3-one | Formula: | C22 H21 N7 O2 S | SMILES: | COc1ccc2nccc(n3cc(CCNCc4ccc5SCC(=O)Nc5c4)nn3)c2n1 | InChi: | InChI=1S/C22H21N7O2S/c1-31-21-5-3-16-22(26-21)18(7-9-24-16)29-12-15(27-28-29)6-8-23-11-14-2-4-19-17(10-14)25-20(30)13-32-19/h2-5,7,9-10,12,23H,6,8,11,13H2,1H3,(H,25,30) | Definition date: | 2024-03-05 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 6-[[2-[1-(6-methoxy-1,5-naphthyridin-4-yl)-1,2,3-triazol-4-yl]ethylamino]methyl]-4~{H}-1,4-benzothiazin-3-one |
|
 | A1H8X | Name: | 4-fluoranyl-~{N}-[(2~{S})-1-[[4-[(2-methyl-1-oxidanyl-propan-2-yl)sulfamoyl]phenyl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]benzamide | Formula: | C26 H28 F N3 O5 S | SMILES: | CC(C)(CO)N[S](=O)(=O)c1ccc(NC(=O)[CH](Cc2ccccc2)NC(=O)c3ccc(F)cc3)cc1 | InChi: | InChI=1S/C26H28FN3O5S/c1-26(2,17-31)30-36(34,35)22-14-12-21(13-15-22)28-25(33)23(16-18-6-4-3-5-7-18)29-24(32)19-8-10-20(27)11-9-19/h3-15,23,30-31H,16-17H2,1-2H3,(H,28,33)(H,29,32) | Synonyms: | NK036 USP30 inhibitor | Definition date: | 2024-04-20 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 4-fluoranyl-~{N}-[(2~{S})-1-[[4-[(2-methyl-1-oxidanyl-propan-2-yl)sulfamoyl]phenyl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]benzamide |
|
 | UQF | Name: | 1-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]propyl]guanidine | Formula: | C27 H36 N14 O7 | SMILES: | NC(=N)NCCCN(CC#Cc1nc2c(N)ncnc2n1[CH]3O[CH](CO)[CH](O)[CH]3O)C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56 | InChi: | InChI=1S/C27H36N14O7/c28-21-15-23(35-9-33-21)40(11-37-15)25-19(45)17(43)12(47-25)7-39(6-2-4-32-27(30)31)5-1-3-14-38-16-22(29)34-10-36-24(16)41(14)26-20(46)18(44)13(8-42)48-26/h9-13,17-20,25-26,42-46H,2,4-8H2,(H2,28,33,35)(H2,29,34,36)(H4,30,31,32)/t12-,13?,17+,18+,19+,20+,25-,26-/m0/s1 | Definition date: | 2023-09-06 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 1-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]propyl]guanidine |
|
 | UDL | Name: | (2~{S},3~{R})-2-acetamido-4-methyl-3-oxidanyl-pentanoic acid | Formula: | C8 H15 N O4 | SMILES: | CC(C)[CH](O)[CH](NC(C)=O)C(O)=O | InChi: | InChI=1S/C8H15NO4/c1-4(2)7(11)6(8(12)13)9-5(3)10/h4,6-7,11H,1-3H3,(H,9,10)(H,12,13)/t6-,7+/m0/s1 | Definition date: | 2023-09-04 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | (2~{S},3~{R})-2-acetamido-4-methyl-3-oxidanyl-pentanoic acid |
|
 | KN6 | Name: | 4-THIOPYRIDINE | Formula: | C5 H5 N S | SMILES: | Sc1ccncc1 | InChi: | InChI=1S/C5H5NS/c7-5-1-3-6-4-2-5/h1-4H,(H,6,7) | Synonyms: | pyridine-4-thiol | Definition date: | 2024-01-22 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | pyridine-4-thiol |
|
 | UTR | Name: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-[8-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy]prop-1-ynyl]-6-azanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylcarbamoyl]benzoic acid | Formula: | C31 H31 N11 O10 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](COCC#Cc4nc5c(N)ncnc5n4[CH]6O[CH](CNC(=O)c7ccccc7C(O)=O)[CH](O)[CH]6O)[CH](O)[CH]3O | InChi: | InChI=1S/C31H31N11O10/c32-24-18-26(37-10-35-24)41(12-39-18)29-22(45)21(44)16(52-29)9-50-7-3-6-17-40-19-25(33)36-11-38-27(19)42(17)30-23(46)20(43)15(51-30)8-34-28(47)13-4-1-2-5-14(13)31(48)49/h1-2,4-5,10-12,15-16,20-23,29-30,43-46H,7-9H2,(H,34,47)(H,48,49)(H2,32,35,37)(H2,33,36,38)/t15-,16-,20-,21-,22-,23-,29-,30-/m1/s1 | Definition date: | 2023-09-07 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 2-[[(2~{R},3~{S},4~{R},5~{R})-5-[8-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy]prop-1-ynyl]-6-azanyl-purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylcarbamoyl]benzoic acid |
|